Stock screener

LMAT

Conviction 42HealthcareScan · Thu, Jun 25, 2026
LMAT$93.91+1.80%
ResistanceSupportVol 14Insider sell
63 bars
2
2
Vol MA14 367.21K
Mar 26Apr 14May 1May 19Jun 8Jun 25
LEMAITRE VASCULAR INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.lemaitre.com ↗
Price93.91
Change+1.80%
Gap+0.73%
Rel volume2.15×
Avg volume346K
Avg $ vol32.21M
SMA 2092.92
SMA 50101.20
SMA 20094.21
Price vs 50-7.20%
Price vs 200-0.32%
MA stackmixed
50/200 cross—
Supertrenddown · 100.98
RSI (14)47
MACD hist0.51
MACD cross—
Stoch %K / %D58 / 45
ADX (14)32
+DI / −DI16 / 24
RSI divergence—
MACD divergence—
ATR %+3.51%
ADR %3.10%
52w high117.39
52w low79.77
From 52w high-20.00%
Above 52w low+17.73%
New 52w highNo
SqueezeOn · 3d
Bollinger width7.31%
%B0.65
Donchian pos57.58%
Donchian high97.83
Donchian low88.59
AVWAP (52w high)99.79
vs AVWAP high-5.89%
AVWAP (52w low)95.82
vs AVWAP low-1.99%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d2.15×
Avg vol (14d)367.2K
Avg vol (20d)346K
Avg $ vol (20d)32.21M
Market cap2.15B
RS 3m (vs SPY)-28.39%
RS 6m (vs SPY)+0.84%
RS line new highNo
Trend template3/8
Technical rank48.8
1 week+1.84%
1 month-4.86%
3 months-15.46%
6 months+11.12%
1 year+10.74%
YTD+17.14%
P/E37.17
P/B5.28
P/S8.60
P/FCF27.37
EPS2.52
Div yield0.84%
ROE14.20%
ROA9.17%
Debt/Eq—
Current14.32
EV/EBITDA27.05
Gross margin71.53%
Net margin23.13%
Rev growth13.53%
EPS growth31.10%
Price target123.00
Target upside30.98%
Analyst ratingBuy
Institutional105.41%
Ent. value2.12B
Revenue54.82M
Net income15.68M
Gross profit48.4M
Free cash flow78.41M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out22.85M
Employees655
ListedThu, Oct 19, 2006
Free float21.15M
Float %92.6%
Short interest1.19M
Days to cover3.7d
Short volume72.1%
Squeeze score65 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.81 · 2 est
Last EPS vs est$0.68 vs $0.66
Last surprise+3.0% beat
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank48.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance109.49
Support89.44
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LMAT

All disclosures →
No recent disclosed trades by Congress in LMAT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LMAT · 10 buys

InsiderSideShares
Pellegrino Joseph P JR
Director · Dividend Equivalent Rights · 2026-06-04
Grant1.427
Roberts David B
President and Director · Dividend Equivalent Rights · 2026-06-04
Grant0.297
O'Connor John James
Director · Dividend Equivalent Rights · 2026-06-04
Grant0.466
LeMaitre George W
Chairman and CEO · Dividend Equivalent Rights · 2026-06-04
Grant11.359
Jasinski Lawrence J
Director · Dividend Equivalent Rights · 2026-06-04
Grant1.427
LeBlanc Dorian Paul
Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04
Grant2.476
Roberts David B
President and Director · Dividend Equivalent Rights · 2026-06-04
Grant3.068
Pellegrino Joseph P JR
Director · Dividend Equivalent Rights · 2026-06-04
Grant3.734
LeMaitre George W
Chairman and CEO · Dividend Equivalent Rights · 2026-06-04
Grant16.805
LeBlanc Dorian Paul
Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04
Grant3.152

SEC filings

EDGAR filings in LMAT · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.